| Two novel BRM insertion promoter sequence variants are associated with loss of BRM expression and lung cancer risk G Liu, S Gramling, D Munoz, D Cheng, AK Azad, M Mirshams, Z Chen, ... Oncogene 30 (29), 3295-3304, 2011 | 61 | 2011 |
| Validation of genetic sequence variants as prognostic factors in early-stage head and neck squamous cell cancer survival AK Azad, I Bairati, E Samson, D Cheng, M Mirshams, X Qiu, S Savas, ... Clinical Cancer Research 18 (1), 196-206, 2012 | 48 | 2012 |
| Association of two BRM promoter polymorphisms with head and neck squamous cell carcinoma risk JR Wang, SJB Gramling, DP Goldstein, D Cheng, D Chen, AK Azad, ... Carcinogenesis 34 (5), 1012-1017, 2013 | 40 | 2013 |
| Socioeconomic status, human papillomavirus, and overall survival in head and neck squamous cell carcinomas in Toronto, Canada KP Chu, S Habbous, Q Kuang, K Boyd, M Mirshams, FF Liu, ... Cancer epidemiology 40, 102-112, 2016 | 35 | 2016 |
| Measuring financial toxicity incurred after treatment of head and neck cancer: Development and validation of the Financial Index of Toxicity questionnaire K Hueniken, CM Douglas, AR Jethwa, M Mirshams, L Eng, A Hope, ... Cancer 126 (17), 4042-4050, 2020 | 32 | 2020 |
| Genetic sequence variants and the development of secondary primary cancers in patients with head and neck cancers AK Azad, I Bairati, E Samson, D Cheng, L Cheng, M Mirshams, S Savas, ... Cancer 118 (6), 1554-1565, 2012 | 27 | 2012 |
| Two BRM promoter insertion polymorphisms increase the risk of early‐stage upper aerodigestive tract cancers KM Wong, X Qiu, D Cheng, AK Azad, S Habbous, P Palepu, M Mirshams, ... Cancer Medicine 3 (2), 426-433, 2014 | 18 | 2014 |
| Out‐of‐pocket costs associated with head and neck cancer treatment MN Khan, K Hueniken, M Manojlovic‐Kolarski, L Eng, M Mirshams, ... Cancer Reports 5 (7), e1528, 2022 | 13 | 2022 |
| Association between genetic variants and cisplatin-induced nephrotoxicity: a genome-wide approach and validation study Z Zazuli, C de Jong, W Xu, SJH Vijverberg, R Masereeuw, D Patel, ... Journal of personalized medicine 11 (11), 1233, 2021 | 8 | 2021 |
| Multiple imputation and clinico‐serological models to predict human papillomavirus status in oropharyngeal carcinoma: an alternative when tissue is unavailable J Ren, W Xu, J Su, X Ren, D Cheng, Z Chen, N Bender, M Mirshams, ... International journal of cancer 146 (8), 2166-2174, 2020 | 8 | 2020 |
| Nicotine dependence as a risk factor for upper aerodigestive tract (UADT) cancers: A mediation analysis S Thomas, JC Carroll, MC Brown, Z Chen, M Mirshams, D Patel, K Boyd, ... Plos one 15 (8), e0237723, 2020 | 7 | 2020 |
| HPV status improves classification of head and neck gray zone cancers J Ren, W Xu, J Su, X Ren, N Bender, S Habbous, JR de Almeida, ... Journal of Dental Research 98 (8), 879-887, 2019 | 6 | 2019 |
| Two BRM promoter polymorphisms and risk of early stage (Stage I-II) upper aerodigestive tract cancer risk K Wong, X Qiu, D Cheng, AK Azad, P Palepu, M Mirshams, D Patel, ... J Clin Oncol 30 (Suppl), 2012 | 5 | 2012 |
| The effect of two BRM promoter variants on the risk of stage I/II upper aerodigestive tract cancers. KM Wong, X Qiu, D Cheng, AK Azad, PR Palepu, M Mirshams, D Patel, ... Journal of Clinical Oncology 30 (15_suppl), 10522-10522, 2012 | 4 | 2012 |
| A genome-wide association study of non-HPV-related head and neck squamous cell carcinoma identifies prognostic genetic sequence variants in the MAP-kinase and hormone pathways AK Azad, I Bairati, X Qiu, H Girgis, L Cheng, D Waggott, D Cheng, ... Cancer Epidemiology 42, 173-180, 2016 | 3 | 2016 |
| The basket or umbrella real-world observational study (BUROS) design for molecular cancer subtypes G Liu, S Raptis, M Mirshams, D Patel, S Chotai, A Ghattas, A Zarrin, A Stitt, ... PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 29, 421-421, 2020 | | 2020 |
| 947P Association between genetic variants and cisplatin nephrotoxicity: A genome-wide approach Z Zazuli, W Xu, S Vijverberg, R Masereeuw, M Mirshams, K Khan, ... Annals of Oncology 31, S674, 2020 | | 2020 |
| Cisplatin-induced ototoxicity in head and neck squamous cell carcinoma (HNSCC) patients treated with chemoradiation: The role of WFS1 and ABCC2 heritable variants. M Mahler, Y Zhang, K Hueniken, MC Brown, Z Chen, M Mirshams, ... Journal of Clinical Oncology 36 (15_suppl), 6048-6048, 2018 | | 2018 |
| The Willingness Of Cancer Outpatients To Complete Patient-Reported Outcome Measures Outside Of The Clinic V Ho, Y Song, C Brown, A Vennettilli, L Eng, A Zarrin, A Dobriyal, L Chen, ... Value in Health 18 (7), A470-A471, 2015 | | 2015 |
| Using tablet technology in routine patient-reported outcome measure surveys to improve cancer quality care: A patient acceptability assessment. V Pat, C Brown, A Vennettilli, A Zarrin, A Dobriyal, L Chen, M Mirshams, ... Journal of Clinical Oncology 32 (30_suppl), 155-155, 2014 | | 2014 |
